Amba is a program developed by Pfizer and available to patients of a specialty pharmacy who have been prescribed a certain treatment fora specific type of metastatic breast cancer. Amba Is available in English. If you’ve opted in with your specialty pharmacy provider but have not received an email or text message with the opt-in code, please contact [email protected]. Technical help needed? Contact us at [email protected].